While the FII is determined in healthy subjects, our previous studies suggest that the FII may be relevant to predicting exogenous prandial insulin doses in type 1 diabetes [21,22] and reducing postprandial insulinaemia in type 2 diabetes [23]. The gene discussed is INS; the disease is type 2 diabetes mellitus.